We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$82.1B
AUM Growth
+$7.21B
Cap. Flow
+$2.14B
Cap. Flow %
2.6%
Top 10 Hldgs %
34.14%
Holding
3,101
New
616
Increased
843
Reduced
896
Closed
659

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$495M
2
SPOT icon
Spotify
SPOT
+$377M
3
HUM icon
Humana
HUM
+$350M
4
GS icon
Goldman Sachs
GS
+$324M
5
MRK icon
Merck
MRK
+$307M

Sector Composition

Rank Sector Weight
1 Technology 18.11%
2 Consumer Discretionary 14.61%
3 Healthcare 12.89%
4 Industrials 6.78%
5 Financials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPO icon
1526
Exponent
EXPO
$3.04B
$1.26M ﹤0.01%
10,900
-2,469
-18% -$258K
USAP
1527
DELISTED
Universal Stainless & Alloy
USAP
$1.26M ﹤0.01%
32,527
-29,692
-48% -$1.06M
MGNX icon
1528
MacroGenics
MGNX
$254M
$1.26M ﹤0.01%
381,516
-276,491
-42% -$1.08M
JSPR icon
1529
Jasper Therapeutics
JSPR
$23.1M
$1.25M ﹤0.01%
+66,325
New +$1.32M
GOOGL icon
1530
PUT
Alphabet (Google) Class A
GOOGL
$3.99T
$1.24M ﹤0.01%
7,500
-25,400
-77% -$4.26M
SABS icon
1531
SAB Biotherapeutics
SABS
$263M
$1.24M ﹤0.01%
459,168
CVBF icon
1532
CVB Financial
CVBF
$3.97B
$1.23M ﹤0.01%
69,240
+19,605
+39% +$350K
RRGB icon
1533
Red Robin
RRGB
$136M
$1.23M ﹤0.01%
279,748
-88,793
-24% -$434K
FIACW
1534
CALL
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
$1.23M ﹤0.01%
112,928
-654
-0.6% -$25
PD icon
1535
PagerDuty
PD
$753M
$1.23M ﹤0.01%
66,298
+20,198
+44% +$394K
CEVA icon
1536
CEVA Inc
CEVA
$980M
$1.22M ﹤0.01%
+50,679
New +$1.1M
LTM
1537
LATAM Airlines Group S.A.
LTM
$15B
$1.22M ﹤0.01%
+46,050
New +$1.15M
EC icon
1538
Ecopetrol
EC
$32.5B
$1.22M ﹤0.01%
+136,096
New +$1.38M
PRCT icon
1539
Procept Biorobotics
PRCT
$1.01B
$1.21M ﹤0.01%
15,152
+5,869
+63% +$417K
ENIC icon
1540
Enel Chile
ENIC
$6.05B
$1.21M ﹤0.01%
435,002
+265,882
+157% +$733K
CSIQ icon
1541
Canadian Solar
CSIQ
$936M
$1.21M ﹤0.01%
72,354
+12,211
+20% +$178K
FMS icon
1542
Fresenius Medical Care
FMS
$13.4B
$1.21M ﹤0.01%
56,841
+41,478
+270% +$816K
TBPH icon
1543
Theravance Biopharma
TBPH
$874M
$1.21M ﹤0.01%
150,060
-147,439
-50% -$1.28M
AAXJ icon
1544
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.66B
$1.2M ﹤0.01%
+15,330
New +$1.11M
CACC icon
1545
Credit Acceptance
CACC
$5.78B
$1.2M ﹤0.01%
2,706
-6,774
-71% -$3.33M
AIN icon
1546
Albany International
AIN
$2.16B
$1.2M ﹤0.01%
13,477
+4,071
+43% +$358K
XPOF icon
1547
Xponential Fitness
XPOF
$278M
$1.2M ﹤0.01%
96,387
-790,023
-89% -$11.6M
IMAQW
1548
CALL
DELISTED
International Media Acquisition Corp. Warrants
IMAQW
$1.19M ﹤0.01%
110,000
EH
1549
EHang Holdings
EH
$398M
$1.19M ﹤0.01%
84,352
+73,932
+710% +$968K
ADBE icon
1550
PUT
Adobe
ADBE
$94.5B
$1.19M ﹤0.01%
2,300
-71,900
-97% -$39.4M

Similar funds

Marshall Wace's Q3 2024 Portfolio in Review

As of Q3 2024, Marshall Wace held 3,101 positions worth $82.1B, up 9.6% from $74.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Marshall Wace's Q3 2024 filing shows 616 new, 843 increased, 896 reduced and 659 closed positions. Its largest new stake was Texas Instruments: 1,008,812 shares worth $208M. The largest sale was Costco, an estimated $495M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q3 2024 buy was Texas Instruments: 1,008,812 shares worth $208M.
  • Marshall Wace added most to Tesla in Q3 2024, an estimated $700M increase.
  • Marshall Wace's biggest Q3 2024 reduction was Costco, cutting an estimated $495M.
  • Marshall Wace fully exited Shopify in Q3 2024, selling an estimated $209M.
  • Marshall Wace's ten largest holdings make up 34% of its $82.1B portfolio in Q3 2024.
  • Marshall Wace opened 616 new positions and closed 659 in Q3 2024.
  • Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $82.1B.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.